ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,642Medicare Part D Prescriptions Filled, Including Refills

Rank: 368 out of 2094

$466K Total Retail Price of All Prescriptions

Rank: 549 out of 2094

471 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 6,508 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 280 246 1 3
AMLODIPINE BESYLATE 270 260 2 2
FUROSEMIDE 257 217 3 6
METOPROLOL TARTRATE 242 235 4 10
OMEPRAZOLE 192 146 5 4
METFORMIN HCL 155 146 6 8
PRAVASTATIN SODIUM 154 141 7 18
WARFARIN SODIUM 153 123 8 11
GABAPENTIN 149 144 9 23
LISINOPRIL 146 129 10 7
MIRTAZAPINE 145 142 11 43
SIMVASTATIN 132 116 12 1
SERTRALINE HCL 115 106 13 26
POTASSIUM CHLORIDE 107 90 14 24
HYDROCODONE-ACETAMINOPHEN 101 39 S3 15 42
FAMOTIDINE 101 100 15 34
RISPERIDONE 87 84 17 56
ISOSORBIDE MONONITRATE ER 86 85 18 57
TAMSULOSIN HCL 86 67 18 29
ATORVASTATIN CALCIUM 83 81 20 5
CARVEDILOL 83 72 20 19
HYDRALAZINE HCL 81 78 22 89
LOSARTAN POTASSIUM 74 70 23 17
ESCITALOPRAM OXALATE 69 69 24 46
MUPIROCIN 67 39 25 117
NAMENDA 66 55 26 32
CLOPIDOGREL 66 60 26 22
DONEPEZIL HCL 65 63 28 20
METOPROLOL SUCCINATE 64 43 29 9
TRAMADOL HCL 62 49 30 33
TRAZODONE HCL 60 49 31 72
DIGOXIN 60 60 31 51
ATENOLOL 58 49 33 21
LANTUS 57 47 34 66
CITALOPRAM HBR 57 53 34 47
LEVOFLOXACIN 56 44 36 70
EXELON 53 53 37 111
DIVALPROEX SODIUM 53 51 37 69
SANTYL 51 28 39 114
JANUVIA 51 45 39 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.